\-\ Texto\\:\\ \ \(0\)\
\-\ initial\\ vital\\ signs\\ demonstrated\\ afebrile\\ pt\\ with\\ bp\\ 159\\/77\\,\\ hr\\ 82\\,\\ rr\\ 22\\.\\ \\ initial\\ exam\\ wnl\\,\\ including\\ neurologic\\ exam\\.\\ \\ hd\\#5\\,\\ mild\\ gait\\ disturbance\\ noted\\ with\\ deviation\\ to\\ the\\ left\\,\\ and\\ deficits\\ in\\ high\\ level\\ and\\ dynamic\\ gait\\ activity\\.\ \(0\)\
\-\ labs\\:\\ spep\\,\\ protein\\ c\\,\\ protein\\ s\\,\\ antithrombin\\ iii\\,\\ hypercoag\\ panel\\,\\ ana\\,\\ ena\\,\\ rf\\,\\ b12\\,\\ folate\\,\\ mma\\,\\ coagii\\,\\ esr\\,\\ crp\\,\\ homocysteine\\,\\ cardiolipin\\ panel\\,\\ rpr\\,\\ lipid\\ panel\\ all\\ wnl\\.\\ \ \(0\)\
\-\ an\\ lp\\ was\\ performed\\ and\\ wnl\\.\ \(0\)\
\-\ tte\\ and\\ tee\\ both\\ showed\\ no\\ abnormalities\\ or\\ clots\\.\ \(0\)\
\-\ this\\ pt\\ is\\ being\\ transitioned\\ from\\ effexor\\ to\\ zoloft\\,\\ his\\ htn\\ is\\ being\\ addressed\\ with\\ hctz\\,\\ and\\ he\\ will\\ receive\\ rehabilitative\\ treatment\\ from\\ pm\\&r\\ and\\ physical\\ therapy\\.\\ \\ \\ \ \(0\)\
\-\ his\\ medical\\ conditions\\ will\\ continue\\ to\\ be\\ followed\\ by\\ psychiatry\\,\\ medicine\\,\\ and\\ neurology\\.\ \(0\)\
\-\ \\‚\\Ä\\¢ct\\ on\\ hd\\#1\\ demonstrated\\ no\\ evidence\\ of\\ infarction\\,\\ inflammation\\,\\ or\\ bleeding\\.\ \(0\)\
\-\ \\‚\\Ä\\¢ct\\ on\\ hd\\#3\\ showed\\ a\\ change\\ in\\ density\\ in\\ areas\\ of\\ the\\ left\\ cerebellum\ \(0\)\
\-\ \\‚\\Ä\\¢mri\\/mra\\ of\\ the\\ head\\ and\\ brain\\ on\\ hd\\#4\\ demonstrated\\ subacute\\ l\\ pica\\ territory\\ infarcts\\ and\\ normal\\ intracranial\\ mra\\.\ \(0\)\
\-\ \\‚\\Ä\\¢mri\\/mra\\ of\\ the\\ neck\\ on\\ hd\\#5\\ demonstrated\\ no\\ dissection\\,\\ aneurysm\\ or\\ focal\\ stenosis\\ of\\ the\\ vertebral\\ arteries\\.\ \(0\)\
\-\ cerebellar\\ pica\\ infarction\ \(0\)\
\-\ \\‚\\Ä\\¢\\ cerebellar\\ embolic\\ infarction\ \(0\)\
\-\ \\‚\\Ä\\¢\\ vertebral\\ artery\\ dissection\ \(0\)\
\-\ 47\\ yo\\ man\\ with\\ 6\\ month\\ hx\\ of\\ headaches\\ \\-\\ now\\ reports\\ experiencing\\ \\‚\\Ä\\úworst\\ headache\\ of\\ his\\ life\\‚\\Ä\\ù\\ accompanied\\ by\\ nausea\\,\\ vomiting\\,\\ and\\ dizziness\\.\\ pt\\ notes\\ waking\\ up\\ with\\ a\\ mild\\ headache\\ on\\ the\\ day\\ of\\ admission\\,\\ unrelieved\\ by\\ caffeine\\ consumption\\,\\ that\\ progressively\\ worsened\\.\\ the\\ pain\\ was\\ sharp\\,\\ but\\ throbbing\\ and\\ located\\ behind\\ his\\ left\\ eye\\ and\\ radiating\\ posteriorly\\.\ \(0\)\
\-\ this\\ patient\\ had\\ an\\ atypical\\ presentation\\ for\\ stroke\\,\\ without\\ any\\ of\\ the\\ classic\\ risk\\ factors\\.\\ \\ while\\ it\\ is\\ true\\ that\\ headaches\\ are\\ sometimes\\ seen\\ with\\ stroke\\,\\ this\\ patient\\ had\\ no\\ focal\\ neurologic\\ findings\\ at\\ the\\ time\\ of\\ his\\ presentation\\,\\ which\\ confused\\ the\\ picture\\.\\ \\ his\\ headache\\ presentation\\ was\\ most\\ consistent\\ with\\ migraine\\,\\ if\\ one\\ assumes\\ a\\ primary\\ headache\\.\\ \\ if\\ one\\ looks\\ further\\ for\\ causes\\ of\\ secondary\\ headache\\,\\ the\\ differential\\ includes\\ subarachnoid\\ hemorrhage\\ \\(sah\\)\\,\\ aneurysm\\,\\ acute\\ ischemic\\ cerebrovascular\\ disorder\\,\\ arteritis\\,\\ artery\\ dissection\\,\\ hypertension\\(htn\\)\\,\\ pseudotumor\\ cerebri\\,\\ infection\\,\\ and\\ substance\\ use\\ or\\ withdrawal\\.\\ \\ \ \(0\)\
\-\ \\	in\\ this\\ case\\,\\ the\\ team\\ did\\ a\\ ct\\ for\\ bleeding\\ including\\ sah\\ and\\ mass\\ effect\\,\\ which\\ was\\ negative\\,\\ blood\\ work\\ to\\ rule\\ out\\ arteritis\\ and\\ infection\\,\\ and\\ \\(later\\)\\ an\\ mra\\ to\\ examine\\ the\\ arteries\\,\\ which\\ was\\ also\\ normal\\ everywhere\\ but\\ the\\ l\\ pica\\.\\ physical\\ exam\\ and\\ lumbar\\ puncture\\ ruled\\ out\\ pseudotumor\\ cerebri\\ in\\ this\\ case\\.\\ that\\ leaves\\ htn\\,\\ ischemia\\/infarct\\,\\ and\\ substance\\ or\\ drug\\ use\\ or\\ withdrawal\\.\ \(0\)\
\-\ \\	the\\ patient\\'s\\ systolic\\ blood\\ pressure\\ was\\ elevated\\ on\\ presentation\\,\\ and\\ with\\ further\\ digging\\,\\ continued\\ to\\ remain\\ elevated\\ during\\ his\\ hospital\\ course\\ \\(with\\ diastolic\\ also\\ elevated\\ most\\ of\\ the\\ time\\)\\.\\ it\\ is\\ possible\\ that\\ his\\ blood\\ pressure\\ had\\ been\\ elevated\\ for\\ quite\\ some\\ time\\,\\ leading\\ to\\ an\\ occult\\ risk\\ factor\\.\\ \\ if\\ his\\ headache\\ was\\ a\\ caused\\ by\\ a\\ hypertensive\\ crisis\\,\\ one\\ would\\ expect\\ his\\ blood\\ pressure\\ to\\ be\\ further\\ elevated\\ on\\ presentation\\.\\ \ \(0\)\
\-\ \\	the\\ patient\\ was\\ taking\\ effexor\\ \\(venlafaxine\\)\\,\\ which\\ is\\ a\\ selective\\ serotonin\\/\\ norepinephrine\\ reuptake\\ inhibitor\\(snri\\)\\,\\ and\\ has\\ both\\ htn\\ and\\ headaches\\ as\\ possible\\ side\\ effects\\.\\ \\ stroke\\ is\\ not\\ listed\\ as\\ a\\ known\\ side\\ effect\\.\\ \\ however\\,\\ there\\ is\\ one\\ case\\ study\\ in\\ the\\ literature\\ that\\ describes\\ a\\ patient\\ having\\ a\\ \\"migraine\\-like\\"\\ stroke\\ while\\ having\\ a\\ serotonin\\ syndrome\\.\\ \\ serotonin\\ syndrome\\ is\\ caused\\ by\\ too\\ much\\ serotonin\\ in\\ the\\ brain\\,\\ usually\\ secondary\\ to\\ patients\\ taking\\ ssris\\/\\ snris\\ and\\ then\\ taking\\ a\\ second\\ serotonin\\ promoter\\.\\ \\ it\\ does\\ sometimes\\ occur\\ when\\ patients\\ are\\ taking\\ elevated\\ doses\\ of\\ medication\\.\\ \\ it\\ is\\ unknown\\ how\\ long\\ this\\ patient\\ was\\ taking\\ effexor\\ before\\ his\\ headaches\\ began\\ or\\ if\\ he\\ experienced\\ any\\ of\\ the\\ other\\ symptoms\\ of\\ serotonin\\ syndrome\\,\\ including\\ acute\\ mental\\ status\\ changes\\,\\ involuntary\\ movements\\,\\ altered\\ muscle\\ tone\\,\\ and\\ autonomic\\ instability\\.\\ \\ even\\ if\\ the\\ patient\\ did\\ not\\ have\\ serotonin\\ syndrome\\ on\\ presentation\\,\\ it\\ is\\ worth\\ noting\\ that\\ he\\ received\\ sumatriptan\\ while\\ in\\ the\\ hospital\\,\\ while\\ also\\ receiving\\ his\\ venlafaxine\\.\\ \\ \\ could\\ this\\ combination\\ have\\ precipitated\\ a\\ serotonin\\ syndrome\\?\\ \\ certainly\\,\\ however\\,\\ the\\ patient\\ did\\ not\\ report\\ an\\ increase\\ in\\ symptoms\\ after\\ receiving\\ the\\ drug\\,\\ so\\ the\\ possibility\\ is\\ very\\ slim\\.\ \(0\)\
\-\ \\	cocaine\\ is\\ also\\ associated\\ with\\ stroke\\ in\\ the\\ younger\\ population\\.\\ \\ it\\ is\\ associated\\ with\\ vasoconstriction\\,\\ and\\ has\\ been\\ known\\ to\\ cause\\ slow\\ flow\\ in\\ the\\ vertebrobasilar\\ system\\ \\(which\\ supplies\\ the\\ pica\\)\\,\\ among\\ other\\ cerebral\\ infarcts\\,\\ and\\ htn\\.\\ \\ while\\ this\\ patient\\ does\\ not\\ report\\ any\\ cocaine\\ use\\,\\ it\\ is\\ a\\ possibility\\ to\\ be\\ entertained\\.\ \(0\)\
\-\ \\	the\\ actual\\ cause\\ of\\ this\\ patient\\‚\\Ä\\ôs\\ infarct\\ may\\ never\\ be\\ known\\,\\ in\\ part\\ because\\ we\\ do\\ not\\ know\\ when\\ the\\ actual\\ infarct\\ occurred\\.\\ \\ ct\\ best\\ demonstrates\\ signs\\ of\\ cerebral\\ infarct\\ at\\ least\\ 24\\ hours\\ after\\ the\\ event\\.\\ \\ there\\ are\\ cases\\ of\\ ct\\ being\\ used\\ to\\ identify\\ infarcts\\ earlier\\,\\ but\\ this\\ is\\ generally\\ by\\ identifying\\ secondary\\ signs\\ \\(like\\ a\\ clot\\ in\\ the\\ mca\\)\\ and\\ in\\ the\\ cerebrum\\ rather\\ than\\ the\\ cerebellum\\.\\ \\ \\ the\\ differential\\ for\\ headaches\\ is\\ very\\ broad\\,\\ but\\ stroke\\ must\\ be\\ kept\\ in\\ mind\\ especially\\ when\\ no\\ other\\ obvious\\ cause\\ presents\\ itself\\,\\ as\\ it\\ can\\ often\\ be\\ reversed\\ if\\ found\\ early\\ enough\\.\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ clinch\\,cr\\.\\ evaluation\\ of\\ acute\\ headaches\\ in\\ adults\\.\\ amer\\ fam\\ physician\\.\\ 2001\\ feb15\\;63\\(4\\)\\:685\\-92\\.\ \(0\)\
\-\ molaie\\,\\ m\\.\\ serotonin\\ syndrome\\ presenting\\ with\\ migrainelike\\ stroke\\.\\ headache\\.\\ 1997\\ sep\\;37\\(8\\)\\:519\\-21\\.\ \(0\)\
\-\ nanda\\ a\\,\\ vannemreddy\\ p\\,\\ willis\\ b\\,\\ kelley\\ r\\.\\ stroke\\ in\\ the\\ young\\:\\ relationship\\ of\\ active\\ cocaine\\ use\\ with\\ stroke\\ mechanism\\ and\\ outcome\\.\\ acta\\ neurochir\\ suppl\\.\\ 2006\\;96\\:91\\-6\\.\ \(0\)\
\-\ wardlaw\\ jm\\,\\ mielke\\ o\\.\\ early\\ signs\\ of\\ brain\\ infarction\\ at\\ ct\\:\\ observer\\ reliability\\ and\\ outcome\\ after\\ thrombolytic\\ treatment\\-\\-systematic\\ review\\.\\ radiology\\ 2005\\ may\\;235\\(2\\)\\:444\\-53\\.\\ \\ clinch\\,cr\\.\\ evaluation\\ of\\ acute\\ headaches\\ in\\ adults\\.\\ amer\\ fam\\ physician\\.\\ 2001\\ feb15\\;63\\(4\\)\\:685\\-92\\.\ \(0\)\
\-\ caplan\\ lr\\.\\ posterior\\ circulation\\ cerebrovascular\\ syndromes\\.\\ www\\.uptodate\\.com\\.\\ last\\ updated\\ 21nov2006\\.\\ \ \(0\)\
\-\ oliveira\\-filho\\ j\\,\\ koroshetz\\ wj\\.\\ neuroimaging\\ of\\ acute\\ ischemic\\ stroke\\.\\ www\\.uptodate\\.com\\.\\ last\\ updated\\ may\\ 2006\\.\ \(0\)\
\-\ \\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\ \(1\)\
\-\ pt\\ notes\\ waking\\ up\\ with\\ a\\ mild\\ headache\\ on\\ the\\ day\\ of\\ admission\\,\\ unrelieved\\ by\\ caffeine\\ consumption\\,\\ that\\ progressively\\ worsened\\.\\ the\\ pain\\ was\\ sharp\\,\\ but\\ throbbing\\ and\\ located\\ behind\\ his\\ left\\ eye\\ and\\ radiating\\ posteriorly\\.\\ the\\ nausea\\ and\\ vomiting\\ began\\ just\\ after\\ lunch\\,\\ and\\ shortly\\ after\\ the\\ patient\\ took\\ a\\ motrin\\ for\\ his\\ headache\\.\\ he\\ denied\\ any\\ fevers\\,\\ chills\\,\\ night\\ sweats\\,\\ recent\\ ill\\ contacts\\,\\ or\\ diarrhea\\.\\ the\\ patient\\ was\\ given\\ ativan\\,\\ morphine\\,\\ phenergan\\,\\ zofran\\ and\\ benadryl\\ along\\ with\\ a\\ 1l\\ bolus\\ of\\ ns\\.\\ ct\\ was\\ performed\\ and\\ determined\\ to\\ be\\ negative\\ for\\ acute\\ pathology\\.\\ on\\ day\\ 2\\,\\ the\\ headache\\ had\\ resolved\\ in\\ the\\ am\\,\\ but\\ iv\\ phenergan\\ was\\ required\\ for\\ nausea\\,\\ and\\ the\\ dizziness\\ persisted\\.\\ the\\ patient\\ reported\\ a\\ headache\\ in\\ the\\ afternoon\\,\\ unresolved\\ with\\ 2\\ separate\\ doses\\ of\\ imitrex\\ \\(sumatriptan\\)\\,\\ but\\ partially\\ alleviated\\ with\\ tylenol\\.\\ the\\ patient\\ continued\\ to\\ experience\\ pain\\ the\\ following\\ day\\,\\ so\\ a\\ repeat\\ ct\\ was\\ done\\,\\ which\\ showed\\ a\\ \\‚\\Ä\\úprobable\\ left\\ cerebellar\\ infarct\\‚\\Ä\\ù\\.\ \(0\)\
\-\ pmhx\\:\\ hypertriglyceridemia\\,\\ psoriasis\\,\\ anxiety\\,\\ g6pd\\,\\ crohns\ \(0\)\
\-\ meds\\:\\ lopid\\ \\(gemfibrozil\\)\\,\\ effexor\\ \\(venlafaxine\\)\ \(0\)\
\-\ allergies\\:\\ iodine\\,\\ primaquin\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ serotonin\\:\\ 0\\.2920399353362749\ \(0\)\
\-\ the\\:\\ 0\\.21031716509992374\ \(0\)\
\-\ stroke\\:\\ 0\\.2042086357876434\ \(0\)\
\-\ his\\:\\ 0\\.18644609331339798\ \(0\)\
\-\ headache\\:\\ 0\\.16651322264412735\ \(0\)\
\-\ and\\:\\ 0\\.15881423708696407\ \(0\)\
\-\ hd\\:\\ 0\\.15444021586846068\ \(0\)\
\-\ effexor\\:\\ 0\\.1404686111824819\ \(0\)\
\-\ headaches\\:\\ 0\\.1146570023592354\ \(0\)\
\-\ of\\:\\ 0\\.11172903817287928\ \(0\)\
\-\ pica\\:\\ 0\\.1105054752530459\ \(0\)\
\-\ htn\\:\\ 0\\.10949006999276845\ \(0\)\
\-\ in\\:\\ 0\\.10925351709134758\ \(0\)\
\-\ was\\:\\ 0\\.10714079508219357\ \(0\)\
\-\ taking\\:\\ 0\\.10634646977368735\ \(0\)\
\-\ venlafaxine\\:\\ 0\\.10535145838686143\ \(0\)\
\-\ patient\\:\\ 0\\.09999004907521958\ \(0\)\
\-\ is\\:\\ 0\\.0962177532222479\ \(0\)\
\-\ infarct\\:\\ 0\\.09136334850722214\ \(0\)\
\-\ presentation\\:\\ 0\\.09069707712377031\ \(0\)\
\-\ it\\:\\ 0\\.08992386555721978\ \(0\)\
\-\ elevated\\:\\ 0\\.08981828056960067\ \(0\)\
\-\ cocaine\\:\\ 0\\.08798161393006115\ \(0\)\
\-\ mra\\:\\ 0\\.08686445579513966\ \(0\)\
\-\ syndrome\\:\\ 0\\.07942922470430516\ \(0\)\
\-\ to\\:\\ 0\\.07685574578552595\ \(0\)\
\-\ if\\:\\ 0\\.07655219839962119\ \(0\)\
\-\ but\\:\\ 0\\.0760111700126483\ \(0\)\
\-\ this\\:\\ 0\\.07545493089478846\ \(0\)\
\-\ with\\:\\ 0\\.07309725139198417\ \(0\)\
\-\ acute\\:\\ 0\\.0712737373461515\ \(0\)\
\-\ while\\:\\ 0\\.07095818042084528\ \(0\)\
\-\ amer\\:\\ 0\\.07023430559124096\ \(0\)\
\-\ feb15\\:\\ 0\\.07023430559124096\ \(0\)\
\-\ phenergan\\:\\ 0\\.07023430559124096\ \(0\)\
\-\ panel\\:\\ 0\\.06914118959177266\ \(0\)\
\-\ infarction\\:\\ 0\\.0689542527790545\ \(0\)\
\-\ use\\:\\ 0\\.06720657335418932\ \(0\)\
\-\ clinch\\:\\ 0\\.06711262853056413\ \(0\)\
\-\ ct\\:\\ 0\\.06687984892633399\ \(0\)\
\-\ that\\:\\ 0\\.06670554704059994\ \(0\)\
\-\ on\\:\\ 0\\.06631981947389914\ \(0\)\
\-\ by\\:\\ 0\\.06527532706875641\ \(0\)\
\-\ caffeine\\:\\ 0\\.0648977634080611\ \(0\)\
\-\ sumatriptan\\:\\ 0\\.0648977634080611\ \(0\)\
\-\ infarcts\\:\\ 0\\.06445867400075743\ \(0\)\
\-\ pt\\:\\ 0\\.06321250672180732\ \(0\)\
\-\ waking\\:\\ 0\\.06317978054974396\ \(0\)\
\-\ unrelieved\\:\\ 0\\.06317978054974396\ \(0\)\
\-\ be\\:\\ 0\\.06235509701611168\ \(0\)\
\-\ wnl\\:\\ 0\\.061781712037469655\ \(0\)\
\-\ signs\\:\\ 0\\.06138755661774321\ \(0\)\
\-\ or\\:\\ 0\\.061113041174331695\ \(0\)\
\-\ which\\:\\ 0\\.05990973750133934\ \(0\)\
\-\ dissection\\:\\ 0\\.05983208347987981\ \(0\)\
\-\ throbbing\\:\\ 0\\.05956122122488124\ \(0\)\
\-\ fam\\:\\ 0\\.05865440928670744\ \(0\)\
\-\ consumption\\:\\ 0\\.057843238366564104\ \(0\)\
\-\ cerebrovascular\\:\\ 0\\.057843238366564104\ \(0\)\
\-\ withdrawal\\:\\ 0\\.057843238366564104\ \(0\)\
\-\ any\\:\\ 0\\.05676654433667623\ \(0\)\
\-\ day\\:\\ 0\\.05594991576538572\ \(0\)\
\-\ updated\\:\\ 0\\.05525273762652295\ \(0\)\
\-\ actual\\:\\ 0\\.05472156130588727\ \(0\)\
\-\ sah\\:\\ 0\\.054224679041701376\ \(0\)\
\-\ doses\\:\\ 0\\.054224679041701376\ \(0\)\
\-\ demonstrated\\:\\ 0\\.05398153675840625\ \(0\)\
\-\ cerebellar\\:\\ 0\\.053910408971236855\ \(0\)\
\-\ substance\\:\\ 0\\.05331786710352758\ \(0\)\
\-\ after\\:\\ 0\\.05326325017270819\ \(0\)\
\-\ for\\:\\ 0\\.05324473082171538\ \(0\)\
\-\ he\\:\\ 0\\.05201315775142678\ \(0\)\
\-\ blood\\:\\ 0\\.05101169614422122\ \(0\)\
\-\ notes\\:\\ 0\\.050788713325067104\ \(0\)\
\-\ arteritis\\:\\ 0\\.050788713325067104\ \(0\)\
\-\ cerebri\\:\\ 0\\.050788713325067104\ \(0\)\
\-\ nausea\\:\\ 0\\.05060490911504719\ \(0\)\
\-\ one\\:\\ 0\\.05029013486647594\ \(0\)\
\-\ pressure\\:\\ 0\\.05015972962801546\ \(0\)\
\-\ migraine\\:\\ 0\\.049646027268836455\ \(0\)\
\-\ did\\:\\ 0\\.047257423843522404\ \(0\)\
\-\ including\\:\\ 0\\.04714475461409477\ \(0\)\
\-\ outcome\\:\\ 0\\.04679451838266625\ \(0\)\
\-\ being\\:\\ 0\\.04590559569646707\ \(0\)\
\-\ pseudotumor\\:\\ 0\\.04560771184498479\ \(0\)\
\-\ receiving\\:\\ 0\\.04560771184498479\ \(0\)\
\-\ cr\\:\\ 0\\.045452171141887245\ \(0\)\
\-\ cause\\:\\ 0\\.04487838526152442\ \(0\)\
\-\ showed\\:\\ 0\\.043878654143009815\ \(0\)\
\-\ worsened\\:\\ 0\\.04379602799710738\ \(0\)\
\-\ 2006\\:\\ 0\\.04379602799710738\ \(0\)\
\-\ had\\:\\ 0\\.043763039085648374\ \(0\)\
\-\ not\\:\\ 0\\.04334436946499577\ \(0\)\
\-\ sharp\\:\\ 0\\.043198906922611545\ \(0\)\
\-\ progressively\\:\\ 0\\.04297244933383828\ \(0\)\
\-\ further\\:\\ 0\\.04290671131282906\ \(0\)\
\-\ dizziness\\:\\ 0\\.04286167040184609\ \(0\)\
\-\ known\\:\\ 0\\.042650636421663786\ \(0\)\
\-\ 63\\:\\ 0\\.042433837954253775\ \(0\)\
\-\ behind\\:\\ 0\\.04233049408121041\ \(0\)\
\-\ radiating\\:\\ 0\\.042228519041479076\ \(0\)\
\-\ an\\:\\ 0\\.04198515732044673\ \(0\)\
\-\ 2001\\:\\ 0\\.04145797619948639\ \(0\)\
\-\ also\\:\\ 0\\.04131545626409824\ \(0\)\
\-\ sometimes\\:\\ 0\\.04109981846219712\ \(0\)\
\-\ brain\\:\\ 0\\.04106746748937443\ \(0\)\
\-\ adults\\:\\ 0\\.04101282315304059\ \(0\)\
\-\ began\\:\\ 0\\.04084172715752868\ \(0\)\
\-\ possibility\\:\\ 0\\.04084172715752868\ \(0\)\
\-\ protein\\:\\ 0\\.040757584211335254\ \(0\)\
\-\ cerebellum\\:\\ 0\\.04035013448677873\ \(0\)\
\-\ drug\\:\\ 0\\.03996316847287163\ \(0\)\
\-\ when\\:\\ 0\\.039793442039903044\ \(0\)\
\-\ time\\:\\ 0\\.039046882782483874\ \(0\)\
\-\ secondary\\:\\ 0\\.039046882782483874\ \(0\)\
\-\ ischemic\\:\\ 0\\.03884133280973169\ \(0\)\
\-\ posteriorly\\:\\ 0\\.03871193475634769\ \(0\)\
\-\ physician\\:\\ 0\\.038521826259339906\ \(0\)\
\-\ gait\\:\\ 0\\.03803668923456871\ \(0\)\
\-\ having\\:\\ 0\\.03786236473943169\ \(0\)\
\-\ left\\:\\ 0\\.037453395866855886\ \(0\)\
\-\ mild\\:\\ 0\\.03734372528711537\ \(0\)\
\-\ report\\:\\ 0\\.03699395189803055\ \(0\)\
\-\ so\\:\\ 0\\.03694279554408352\ \(0\)\
\-\ admission\\:\\ 0\\.03664279643766159\ \(0\)\
\-\ continued\\:\\ 0\\.03598516492012541\ \(0\)\
\-\ bleeding\\:\\ 0\\.03589564062137772\ \(0\)\
\-\ last\\:\\ 0\\.03571965574905486\ \(0\)\
\-\ no\\:\\ 0\\.035704014832102685\ \(0\)\
\-\ caused\\:\\ 0\\.03521462207813274\ \(0\)\
\-\ eye\\:\\ 0\\.03513357919356491\ \(0\)\
\-\ hypercoag\\:\\ 0\\.03511715279562048\ \(0\)\
\-\ coagii\\:\\ 0\\.03511715279562048\ \(0\)\
\-\ digging\\:\\ 0\\.03511715279562048\ \(0\)\
\-\ snri\\:\\ 0\\.03511715279562048\ \(0\)\
\-\ snris\\:\\ 0\\.03511715279562048\ \(0\)\
\-\ molaie\\:\\ 0\\.03511715279562048\ \(0\)\
\-\ migrainelike\\:\\ 0\\.03511715279562048\ \(0\)\
\-\ nanda\\:\\ 0\\.03511715279562048\ \(0\)\
\-\ vannemreddy\\:\\ 0\\.03511715279562048\ \(0\)\
\-\ neurochir\\:\\ 0\\.03511715279562048\ \(0\)\
\-\ wardlaw\\:\\ 0\\.03511715279562048\ \(0\)\
\-\ mielke\\:\\ 0\\.03511715279562048\ \(0\)\
\-\ 21nov2006\\:\\ 0\\.03511715279562048\ \(0\)\
\-\ koroshetz\\:\\ 0\\.03511715279562048\ \(0\)\
\-\ zofran\\:\\ 0\\.03511715279562048\ \(0\)\
\-\ lopid\\:\\ 0\\.03511715279562048\ \(0\)\
\-\ neurologic\\:\\ 0\\.03509337543148497\ \(0\)\
\-\ arteries\\:\\ 0\\.03485646434084347\ \(0\)\
\-\ located\\:\\ 0\\.03474068767875486\ \(0\)\
\-\ other\\:\\ 0\\.034210916828352374\ \(0\)\
\-\ antithrombin\\:\\ 0\\.033556314265282064\ \(0\)\
\-\ folate\\:\\ 0\\.033556314265282064\ \(0\)\
\-\ mma\\:\\ 0\\.033556314265282064\ \(0\)\
\-\ zoloft\\:\\ 0\\.033556314265282064\ \(0\)\
\-\ rehabilitative\\:\\ 0\\.033556314265282064\ \(0\)\
\-\ assumes\\:\\ 0\\.033556314265282064\ \(0\)\
\-\ leaves\\:\\ 0\\.033556314265282064\ \(0\)\
\-\ reuptake\\:\\ 0\\.033556314265282064\ \(0\)\
\-\ promoter\\:\\ 0\\.033556314265282064\ \(0\)\
\-\ slim\\:\\ 0\\.033556314265282064\ \(0\)\
\-\ kelley\\:\\ 0\\.033556314265282064\ \(0\)\
\-\ observer\\:\\ 0\\.033556314265282064\ \(0\)\
\-\ lunch\\:\\ 0\\.033556314265282064\ \(0\)\
\-\ ativan\\:\\ 0\\.033556314265282064\ \(0\)\
\-\ 1l\\:\\ 0\\.033556314265282064\ \(0\)\
\-\ imitrex\\:\\ 0\\.033556314265282064\ \(0\)\
\-\ hypertriglyceridemia\\:\\ 0\\.033556314265282064\ \(0\)\
\-\ gemfibrozil\\:\\ 0\\.033556314265282064\ \(0\)\
\-\ primaquin\\:\\ 0\\.033556314265282064\ \(0\)\
\-\ vertebral\\:\\ 0\\.033537482832545665\ \(0\)\
\-\ aneurysm\\:\\ 0\\.03343981975201031\ \(0\)\
\-\ exam\\:\\ 0\\.03316244988096603\ \(0\)\
\-\ may\\:\\ 0\\.03315131879151176\ \(0\)\
\-\ case\\:\\ 0\\.03309582370915852\ \(0\)\
\-\ like\\:\\ 0\\.03264159921834043\ \(0\)\
\-\ vomiting\\:\\ 0\\.032497148396688824\ \(0\)\
\-\ ena\\:\\ 0\\.03244888170403055\ \(0\)\
\-\ everywhere\\:\\ 0\\.03244888170403055\ \(0\)\
\-\ 235\\:\\ 0\\.03244888170403055\ \(0\)\
\-\ caplan\\:\\ 0\\.03244888170403055\ \(0\)\
\-\ hospital\\:\\ 0\\.03244011848448921\ \(0\)\
\-\ early\\:\\ 0\\.03165740971485069\ \(0\)\
\-\ homocysteine\\:\\ 0\\.03158989027487198\ \(0\)\
\-\ cardiolipin\\:\\ 0\\.03158989027487198\ \(0\)\
\-\ hctz\\:\\ 0\\.03158989027487198\ \(0\)\
\-\ wj\\:\\ 0\\.03158989027487198\ \(0\)\
\-\ benadryl\\:\\ 0\\.03158989027487198\ \(0\)\
\-\ ns\\:\\ 0\\.03158989027487198\ \(0\)\
\-\ afternoon\\:\\ 0\\.03158989027487198\ \(0\)\
\-\ g6pd\\:\\ 0\\.03158989027487198\ \(0\)\
\-\ very\\:\\ 0\\.031504949229014936\ \(0\)\
\-\ risk\\:\\ 0\\.03138016525037609\ \(0\)\
\-\ tee\\:\\ 0\\.030888043173692134\ \(0\)\
\-\ psychiatry\\:\\ 0\\.030888043173692134\ \(0\)\
\-\ examine\\:\\ 0\\.030888043173692134\ \(0\)\
\-\ autonomic\\:\\ 0\\.030888043173692134\ \(0\)\
\-\ precipitated\\:\\ 0\\.030888043173692134\ \(0\)\
\-\ vertebrobasilar\\:\\ 0\\.030888043173692134\ \(0\)\
\-\ suppl\\:\\ 0\\.030888043173692134\ \(0\)\
\-\ unresolved\\:\\ 0\\.030888043173692134\ \(0\)\
\-\ effect\\:\\ 0\\.03080783969793469\ \(0\)\
\-\ cerebral\\:\\ 0\\.030426734095837397\ \(0\)\
\-\ does\\:\\ 0\\.030361395630618394\ \(0\)\
\-\ side\\:\\ 0\\.030339738786680875\ \(0\)\
\-\ norepinephrine\\:\\ 0\\.030294639904851404\ \(0\)\
\-\ vasoconstriction\\:\\ 0\\.030294639904851404\ \(0\)\
\-\ supplies\\:\\ 0\\.030294639904851404\ \(0\)\
\-\ spep\\:\\ 0\\.02978061061244062\ \(0\)\
\-\ transitioned\\:\\ 0\\.02978061061244062\ \(0\)\
\-\ cerebrum\\:\\ 0\\.02978061061244062\ \(0\)\
\-\ lr\\:\\ 0\\.02978061061244062\ \(0\)\
\-\ possible\\:\\ 0\\.02975683324830511\ \(0\)\
\-\ initial\\:\\ 0\\.029461816199264093\ \(0\)\
\-\ b12\\:\\ 0\\.02932720464335372\ \(0\)\
\-\ tte\\:\\ 0\\.02932720464335372\ \(0\)\
\-\ looks\\:\\ 0\\.02932720464335372\ \(0\)\
\-\ crisis\\:\\ 0\\.02932720464335372\ \(0\)\
\-\ worth\\:\\ 0\\.02932720464335372\ \(0\)\
\-\ entertained\\:\\ 0\\.02932720464335372\ \(0\)\
\-\ acta\\:\\ 0\\.02932720464335372\ \(0\)\
\-\ alleviated\\:\\ 0\\.02932720464335372\ \(0\)\
\-\ motrin\\:\\ 0\\.028921619183282052\ \(0\)\
\-\ out\\:\\ 0\\.02886786373513475\ \(0\)\
\-\ addressed\\:\\ 0\\.028554722505868352\ \(0\)\
\-\ reversed\\:\\ 0\\.028554722505868352\ \(0\)\
\-\ reliability\\:\\ 0\\.028554722505868352\ \(0\)\
\-\ systematic\\:\\ 0\\.028554722505868352\ \(0\)\
\-\ bolus\\:\\ 0\\.028554722505868352\ \(0\)\
\-\ crohns\\:\\ 0\\.028554722505868352\ \(0\)\
\-\ differential\\:\\ 0\\.028535732654173866\ \(0\)\
\-\ will\\:\\ 0\\.028266744493914798\ \(0\)\
\-\ involuntary\\:\\ 0\\.028219772082102204\ \(0\)\
\-\ willis\\:\\ 0\\.028219772082102204\ \(0\)\
\-\ clots\\:\\ 0\\.027911647561123343\ \(0\)\
\-\ thrombolytic\\:\\ 0\\.027911647561123343\ \(0\)\
\-\ morphine\\:\\ 0\\.027911647561123343\ \(0\)\
\-\ jm\\:\\ 0\\.027626368813261474\ \(0\)\
\-\ artery\\:\\ 0\\.02727594923888883\ \(0\)\
\-\ negative\\:\\ 0\\.02718928037307197\ \(0\)\
\-\ disturbance\\:\\ 0\\.027112339520850688\ \(0\)\
\-\ rpr\\:\\ 0\\.027112339520850688\ \(0\)\
\-\ noting\\:\\ 0\\.027112339520850688\ \(0\)\
\-\ mind\\:\\ 0\\.027112339520850688\ \(0\)\
\-\ psoriasis\\:\\ 0\\.027112339520850688\ \(0\)\
\-\ pm\\:\\ 0\\.02687896494995409\ \(0\)\
\-\ diastolic\\:\\ 0\\.02687896494995409\ \(0\)\
\-\ inhibitor\\:\\ 0\\.02687896494995409\ \(0\)\
\-\ sep\\:\\ 0\\.02687896494995409\ \(0\)\
\-\ evaluation\\:\\ 0\\.026783607819979464\ \(0\)\
\-\ certainly\\:\\ 0\\.02665893355176379\ \(0\)\
\-\ kept\\:\\ 0\\.02665893355176379\ \(0\)\
\-\ neuroimaging\\:\\ 0\\.02665893355176379\ \(0\)\
\-\ infection\\:\\ 0\\.02652896135993536\ \(0\)\
\-\ as\\:\\ 0\\.026465077131430804\ \(0\)\
\-\ lp\\:\\ 0\\.026450801703919394\ \(0\)\
\-\ focal\\:\\ 0\\.0262697111777238\ \(0\)\
\-\ rf\\:\\ 0\\.026253348091692122\ \(0\)\
\-\ selective\\:\\ 0\\.02606553028292306\ \(0\)\
\-\ however\\:\\ 0\\.025994270315228978\ \(0\)\
\-\ performed\\:\\ 0\\.025981981401297986\ \(0\)\
\-\ territory\\:\\ 0\\.025886451414278422\ \(0\)\
\-\ contacts\\:\\ 0\\.025886451414278422\ \(0\)\
\-\ persisted\\:\\ 0\\.025715334288847487\ \(0\)\
\-\ tylenol\\:\\ 0\\.025715334288847487\ \(0\)\
\-\ been\\:\\ 0\\.025587074176843434\ \(0\)\
\-\ ana\\:\\ 0\\.025551500990512274\ \(0\)\
\-\ expect\\:\\ 0\\.025551500990512274\ \(0\)\
\-\ know\\:\\ 0\\.025551500990512274\ \(0\)\
\-\ lipid\\:\\ 0\\.025394356662533552\ \(0\)\
\-\ took\\:\\ 0\\.025243376469533414\ \(0\)\
\-\ anxiety\\:\\ 0\\.025243376469533414\ \(0\)\
\-\ worst\\:\\ 0\\.025098095021425376\ \(0\)\
\-\ listed\\:\\ 0\\.025098095021425376\ \(0\)\
\-\ are\\:\\ 0\\.024997276534726533\ \(0\)\
\-\ at\\:\\ 0\\.02488252820825768\ \(0\)\
\-\ dynamic\\:\\ 0\\.024823013634418228\ \(0\)\
\-\ patients\\:\\ 0\\.024706228546397056\ \(0\)\
\-\ both\\:\\ 0\\.024490786025400814\ \(0\)\
\-\ identifying\\:\\ 0\\.024325612883940004\ \(0\)\
\-\ iodine\\:\\ 0\\.02421069385836416\ \(0\)\
\-\ symptoms\\:\\ 0\\.024029394782643765\ \(0\)\
\-\ experiencing\\:\\ 0\\.023990662460173864\ \(0\)\
\-\ accompanied\\:\\ 0\\.023990662460173864\ \(0\)\
\-\ puncture\\:\\ 0\\.023990662460173864\ \(0\)\
\-\ meds\\:\\ 0\\.023990662460173864\ \(0\)\
\-\ physical\\:\\ 0\\.02381330119799751\ \(0\)\
\-\ describes\\:\\ 0\\.023782530612329465\ \(0\)\
\-\ circulation\\:\\ 0\\.023782530612329465\ \(0\)\
\-\ embolic\\:\\ 0\\.023682537939195\ \(0\)\
\-\ quite\\:\\ 0\\.023585077000102192\ \(0\)\
\-\ occult\\:\\ 0\\.023585077000102192\ \(0\)\
\-\ pain\\:\\ 0\\.02357316884868877\ \(0\)\
\-\ crp\\:\\ 0\\.0234900227515983\ \(0\)\
\-\ team\\:\\ 0\\.0234900227515983\ \(0\)\
\-\ identify\\:\\ 0\\.023397259191333127\ \(0\)\
\-\ enough\\:\\ 0\\.023397259191333127\ \(0\)\
\-\ relationship\\:\\ 0\\.023306678506925478\ \(0\)\
\-\ neurology\\:\\ 0\\.023218180322688492\ \(0\)\
\-\ confused\\:\\ 0\\.023218180322688492\ \(0\)\
\-\ how\\:\\ 0\\.023218180322688492\ \(0\)\
\-\ among\\:\\ 0\\.023218180322688492\ \(0\)\
\-\ pmhx\\:\\ 0\\.023218180322688492\ \(0\)\
\-\ associated\\:\\ 0\\.023148034117046967\ \(0\)\
\-\ receive\\:\\ 0\\.02313167103101529\ \(0\)\
\-\ never\\:\\ 0\\.02313167103101529\ \(0\)\
\-\ picture\\:\\ 0\\.023047063197257557\ \(0\)\
\-\ younger\\:\\ 0\\.022964275028611262\ \(0\)\
\-\ allergies\\:\\ 0\\.022964275028611262\ \(0\)\
\-\ clot\\:\\ 0\\.022883229898922344\ \(0\)\
\-\ most\\:\\ 0\\.022856212391046665\ \(0\)\
\-\ hypertensive\\:\\ 0\\.022803855922492396\ \(0\)\
\-\ effects\\:\\ 0\\.022803855922492396\ \(0\)\
\-\ mca\\:\\ 0\\.022726085570943622\ \(0\)\
\-\ probable\\:\\ 0\\.022726085570943622\ \(0\)\
\-\ syndromes\\:\\ 0\\.022575105377943484\ \(0\)\
\-\ shortly\\:\\ 0\\.022501779323372773\ \(0\)\
\-\ sweats\\:\\ 0\\.022429823929835446\ \(0\)\
\-\ 82\\:\\ 0\\.022359188893529922\ \(0\)\
\-\ altered\\:\\ 0\\.022289826630081614\ \(0\)\
\-\ itself\\:\\ 0\\.022289826630081614\ \(0\)\
\-\ remain\\:\\ 0\\.022221692081991054\ \(0\)\
\-\ deviation\\:\\ 0\\.022088937496455775\ \(0\)\
\-\ systolic\\:\\ 0\\.022088937496455775\ \(0\)\
\-\ too\\:\\ 0\\.022088937496455775\ \(0\)\
\-\ separate\\:\\ 0\\.022024238469763775\ \(0\)\
\-\ ruled\\:\\ 0\\.021960608897578334\ \(0\)\
\-\ have\\:\\ 0\\.02193940705570897\ \(0\)\
\-\ event\\:\\ 0\\.02189801399855369\ \(0\)\
\-\ experience\\:\\ 0\\.021836420660994713\ \(0\)\
\-\ tone\\:\\ 0\\.02177579733767083\ \(0\)\
\-\ up\\:\\ 0\\.021724537213855335\ \(0\)\
\-\ 1997\\:\\ 0\\.021716113948784914\ \(0\)\
\-\ movements\\:\\ 0\\.021657341792350075\ \(0\)\
\-\ continue\\:\\ 0\\.02154242276677423\ \(0\)\
\-\ literature\\:\\ 0\\.021430835200923044\ \(0\)\
\-\ true\\:\\ 0\\.02132239136858393\ \(0\)\
\-\ occurred\\:\\ 0\\.021216918977126888\ \(0\)\
\-\ slow\\:\\ 0\\.021165247040605205\ \(0\)\
\-\ we\\:\\ 0\\.021114259520739538\ \(0\)\
\-\ treatment\\:\\ 0\\.020920432841195862\ \(0\)\
\-\ determined\\:\\ 0\\.02091680590851226\ \(0\)\
\-\ experienced\\:\\ 0\\.020868985399497032\ \(0\)\
\-\ 2005\\:\\ 0\\.020868985399497032\ \(0\)\
\-\ population\\:\\ 0\\.020775090464801506\ \(0\)\
\-\ diarrhea\\:\\ 0\\.020775090464801506\ \(0\)\
\-\ ill\\:\\ 0\\.020728988099743197\ \(0\)\
\-\ am\\:\\ 0\\.020728988099743197\ \(0\)\
\-\ instability\\:\\ 0\\.02068343133761566\ \(0\)\
\-\ mechanism\\:\\ 0\\.02068343133761566\ \(0\)\
\-\ factor\\:\\ 0\\.020593904012489884\ \(0\)\
\-\ subacute\\:\\ 0\\.02054990923109856\ \(0\)\
\-\ obvious\\:\\ 0\\.02042086357876434\ \(0\)\
\-\ combination\\:\\ 0\\.020378792105667627\ \(0\)\
\-\ medication\\:\\ 0\\.020296003937021332\ \(0\)\
\-\ least\\:\\ 0\\.020296003937021332\ \(0\)\
\-\ rr\\:\\ 0\\.020175067243389366\ \(0\)\
\-\ 47\\:\\ 0\\.020135584830902466\ \(0\)\
\-\ esr\\:\\ 0\\.02009650326201166\ \(0\)\
\-\ has\\:\\ 0\\.020060423496655787\ \(0\)\
\-\ conditions\\:\\ 0\\.020057814479353692\ \(0\)\
\-\ earlier\\:\\ 0\\.020057814479353692\ \(0\)\
\-\ hx\\:\\ 0\\.019981584236435816\ \(0\)\
\-\ chills\\:\\ 0\\.019981584236435816\ \(0\)\
\-\ broad\\:\\ 0\\.019833508231782843\ \(0\)\
\-\ denied\\:\\ 0\\.019833508231782843\ \(0\)\
\-\ subarachnoid\\:\\ 0\\.019761552838245516\ \(0\)\
\-\ night\\:\\ 0\\.019726073310856025\ \(0\)\
\-\ resolved\\:\\ 0\\.019726073310856025\ \(0\)\
\-\ part\\:\\ 0\\.019621555538491684\ \(0\)\
\-\ vital\\:\\ 0\\.019553420990401124\ \(0\)\
\-\ leading\\:\\ 0\\.019519800676509057\ \(0\)\
\-\ rather\\:\\ 0\\.019453428317266656\ \(0\)\
\-\ fevers\\:\\ 0\\.019388180967595085\ \(0\)\
\-\ medicine\\:\\ 0\\.019355967378173845\ \(0\)\
\-\ repeat\\:\\ 0\\.019260913129669953\ \(0\)\
\-\ mental\\:\\ 0\\.019137718569259013\ \(0\)\
\-\ received\\:\\ 0\\.019107526246080902\ \(0\)\
\-\ much\\:\\ 0\\.019018344617284355\ \(0\)\
\-\ afebrile\\:\\ 0\\.01896001772156039\ \(0\)\
\-\ iii\\:\\ 0\\.01896001772156039\ \(0\)\
\-\ hr\\:\\ 0\\.0188741516751843\ \(0\)\
\-\ deficits\\:\\ 0\\.0188741516751843\ \(0\)\
\-\ partially\\:\\ 0\\.01884595007306898\ \(0\)\
\-\ must\\:\\ 0\\.01881795357532921\ \(0\)\
\-\ 37\\:\\ 0\\.018707960336057695\ \(0\)\
\-\ generally\\:\\ 0\\.018601022863147538\ \(0\)\
\-\ factors\\:\\ 0\\.018574746300564052\ \(0\)\
\-\ disorder\\:\\ 0\\.018574746300564052\ \(0\)\
\-\ even\\:\\ 0\\.01847139777204176\ \(0\)\
\-\ do\\:\\ 0\\.018200714307907102\ \(0\)\
\-\ young\\:\\ 0\\.018106819373211572\ \(0\)\
\-\ review\\:\\ 0\\.01808369917475342\ \(0\)\
\-\ life\\:\\ 0\\.01801516024602573\ \(0\)\
\-\ atypical\\:\\ 0\\.01801516024602573\ \(0\)\
\-\ normal\\:\\ 0\\.017931389842192984\ \(0\)\
\-\ work\\:\\ 0\\.017903572680174545\ \(0\)\
\-\ bp\\:\\ 0\\.01781657459395157\ \(0\)\
\-\ before\\:\\ 0\\.017752592487174406\ \(0\)\
\-\ lumbar\\:\\ 0\\.017731499275649987\ \(0\)\
\-\ intracranial\\:\\ 0\\.017668904376625345\ \(0\)\
\-\ best\\:\\ 0\\.017668904376625345\ \(0\)\
\-\ inflammation\\:\\ 0\\.01764826356861203\ \(0\)\
\-\ increase\\:\\ 0\\.017627732845431406\ \(0\)\
\-\ radiology\\:\\ 0\\.01758699699999104\ \(0\)\
\-\ just\\:\\ 0\\.017566789596782456\ \(0\)\
\-\ references\\:\\ 0\\.017506796151799436\ \(0\)\
\-\ there\\:\\ 0\\.017474801719352798\ \(0\)\
\-\ done\\:\\ 0\\.017467313739312536\ \(0\)\
\-\ from\\:\\ 0\\.017442333551283055\ \(0\)\
\-\ rule\\:\\ 0\\.017428232170421734\ \(0\)\
\-\ especially\\:\\ 0\\.01737034383937743\ \(0\)\
\-\ pathology\\:\\ 0\\.017238563194763624\ \(0\)\
\-\ presenting\\:\\ 0\\.017201725578994704\ \(0\)\
\-\ reports\\:\\ 0\\.017075501107784614\ \(0\)\
\-\ includes\\:\\ 0\\.017075501107784614\ \(0\)\
\-\ hypertension\\:\\ 0\\.01680164333854733\ \(0\)\
\-\ system\\:\\ 0\\.016752395313275915\ \(0\)\
\-\ hours\\:\\ 0\\.016736118327199963\ \(0\)\
\-\ stenosis\\:\\ 0\\.01670376938497297\ \(0\)\
\-\ change\\:\\ 0\\.01663987577756869\ \(0\)\
\-\ unknown\\:\\ 0\\.01663987577756869\ \(0\)\
\-\ causes\\:\\ 0\\.016592642038080023\ \(0\)\
\-\ second\\:\\ 0\\.016439255154490972\ \(0\)\
\-\ used\\:\\ 0\\.016439255154490972\ \(0\)\
\-\ classic\\:\\ 0\\.016424247332473718\ \(0\)\
\-\ active\\:\\ 0\\.016306245711034343\ \(0\)\
\-\ course\\:\\ 0\\.016220059242244605\ \(0\)\
\-\ occur\\:\\ 0\\.01614968248373928\ \(0\)\
\-\ activity\\:\\ 0\\.016121888128540138\ \(0\)\
\-\ could\\:\\ 0\\.015972506012697767\ \(0\)\
\-\ abnormalities\\:\\ 0\\.015906475208974123\ \(0\)\
\-\ reported\\:\\ 0\\.01581589452456647\ \(0\)\
\-\ later\\:\\ 0\\.015714918204698256\ \(0\)\
\-\ iv\\:\\ 0\\.015690082625188045\ \(0\)\
\-\ required\\:\\ 0\\.01567772466442521\ \(0\)\
\-\ muscle\\:\\ 0\\.015592312253076172\ \(0\)\
\-\ 24\\:\\ 0\\.015568252790559999\ \(0\)\
\-\ would\\:\\ 0\\.01554434276666308\ \(0\)\
\-\ then\\:\\ 0\\.01554434276666308\ \(0\)\
\-\ because\\:\\ 0\\.015346889154435802\ \(0\)\
\-\ status\\:\\ 0\\.015324311368472777\ \(0\)\
\-\ labs\\:\\ 0\\.015213367047918699\ \(0\)\
\-\ given\\:\\ 0\\.015105530823736729\ \(0\)\
\-\ now\\:\\ 0\\.01507376034239904\ \(0\)\
\-\ areas\\:\\ 0\\.01490860894733067\ \(0\)\
\-\ recent\\:\\ 0\\.014868404911170915\ \(0\)\
\-\ followed\\:\\ 0\\.014828616428042223\ \(0\)\
\-\ cases\\:\\ 0\\.014769694336789877\ \(0\)\
\-\ along\\:\\ 0\\.014711660552175002\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.0147020727477875\ \(0\)\
\-\ study\\:\\ 0\\.014645042053255956\ \(0\)\
\-\ flow\\:\\ 0\\.014626218047669939\ \(0\)\
\-\ density\\:\\ 0\\.014561049598201724\ \(0\)\
\-\ long\\:\\ 0\\.014561049598201724\ \(0\)\
\-\ often\\:\\ 0\\.01432821809022083\ \(0\)\
\-\ found\\:\\ 0\\.014208446160976025\ \(0\)\
\-\ medical\\:\\ 0\\.013955795622808543\ \(0\)\
\-\ during\\:\\ 0\\.013908754286242402\ \(0\)\
\-\ usually\\:\\ 0\\.013823977053753243\ \(0\)\
\-\ some\\:\\ 0\\.013816361815915496\ \(0\)\
\-\ yo\\:\\ 0\\.013718710688760516\ \(0\)\
\-\ primary\\:\\ 0\\.013502389653721643\ \(0\)\
\-\ neck\\:\\ 0\\.013432902180838414\ \(0\)\
\-\ month\\:\\ 0\\.013357887378062693\ \(0\)\
\-\ changes\\:\\ 0\\.013271077942030715\ \(0\)\
\-\ level\\:\\ 0\\.01326448067996768\ \(0\)\
\-\ following\\:\\ 0\\.013173286871170491\ \(0\)\
\-\ head\\:\\ 0\\.013096804193649973\ \(0\)\
\-\ all\\:\\ 0\\.013071643963745059\ \(0\)\
\-\ therapy\\:\\ 0\\.012616845014193679\ \(0\)\
\-\ high\\:\\ 0\\.012480032410771712\ \(0\)\
\-\ evidence\\:\\ 0\\.012463936910786575\ \(0\)\
\-\ than\\:\\ 0\\.012447908429038455\ \(0\)\
\-\ consistent\\:\\ 0\\.011906650598998755\ \(0\)\
\-\ noted\\:\\ 0\\.011642606872591938\ \(0\)\
\-\ man\\:\\ 0\\.011625344505226903\ \(0\)\
\-\ without\\:\\ 0\\.01158252424755837\ \(0\)\
\-\ can\\:\\ 0\\.011523364992579126\ \(0\)\
\-\ posterior\\:\\ 0\\.011355166090709974\ \(0\)\
\-\ demonstrates\\:\\ 0\\.011031941236386173\ \(0\)\
\-\ findings\\:\\ 0\\.010837626080799514\ \(0\)\
\-\ presents\\:\\ 0\\.010563391815262675\ \(0\)\
\-\ seen\\:\\ 0\\.010338099179941879\ \(0\)\
\-\ mass\\:\\ 0\\.008387735392265333\ \(0\)\
